Immuno-oncology


How to Stay Current on Immuno-oncology

As Immuno-oncology (I-O) continues to play a more relevant role in cancer treatment, overcoming challenges related to the development of immunotherapies becomes increasingly important. Developing I-O trials requires thoughtful planning. Download ICON’s latest white paper to read about:

  • True Progression & Response Assessment – Apply the most comprehensive markers to assess true efficacy of an immunotherapy
  • Safety Management – Balance antitumour immunity and immunetoxicity with a customised safety management programme
  • Current I-O Market – Overcome challenges in balancing patient, physician, and payer perspectives
  • The Future of I-O – Learn more about promising developments in I-O including checkpoint inhibitors and CAR-T cells.